|
Antivirals
|
| Global Industry Analyst | 699 pages | Octobre 2006 | Anglais
| |
This report analyzes the worldwide markets for Antivirals in US$ Million.
The major product segments analyzed are HIV Antivirals (Reverse Transcriptase Inhibitors (RTIs) (Nucleotide Reverse Transcr ... |
3.160,00 € |
| |
| |
|
|
| |
|
|
US Cough Drops & Throat Lozenges 2005
|
| Snapshots International | 12 pages | Juin 2005 | Anglais
| |
Snapdata's US Cough Drops & Throat Lozenges 2005 report provides 2004 year-end market data, with 2005 estimates and five-year forecasts.
The report gives an instant overview of the US cough drop an ... |
240,00 € |
| |
| |
|
|
| |
|
|
|
|
Pulmonary Drug Delivery Technologies
|
| Global Industry Analyst | 332 pages | Juin 2007 | Anglais
| |
This report analyzes the worldwide markets for Pulmonary Drug Delivery Technologies in Millions of US$.
The specific product segments analyzed are Metered Dose Inhalers (MDIs), Dry Powder Inhalers ... |
3.080,00 € |
| |
| |
|
|
| |
|
|
|
|
UK Market For Personal Protective Equipment
|
| MSI Marketing Research for Industry Ltd | 80 pages | Mai 2002 | Anglais
| |
| This report will enable you to:Analyse the size of the UK market for personal protective equipment, in volume terms, 1997-2006Quantify the size of the UK market for personal protective equipment bet ... |
700,00 € |
| |
| |
|
|
| |
|
|
|
|
US Nasal Products 2004
|
| Snapshots International | 13 pages | Juillet 2004 | Anglais
| |
Snapdata's US Nasal Products 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the US nasal product market, and co ... |
240,00 € |
| |
| |
|
|
| |
|
|
Travel and Tourism Canada
|
| Mintel International | 36 pages | Février 2005 | Anglais
| |
About this report2003 was a grim year for the tourism industry worldwide but Canada was particularly afflicted by the downturn in travel.
As well as external factors such as the Iraq war, which cur ... |
445,00 € |
| |
| |
|
|
| |
|
|
AstraZeneca: PharmaVitae Profile
|
| Datamonitor | 154 pages | Octobre 2006 | Anglais
| |
IntroductionThis analysis examines the historical and forecast performance for AstraZeneca in the ethical pharmaceutical sector.
The profile encompasses global company strategy, portfolio and pipel ... |
4.845,00 € |
| |
| |
|
|
| |
|
